LNCaP prostatic adenocarcinoma cells derived from low and high passage numbers display divergent responses not only to androgens but also to retinoids
- 1 August 1997
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 62 (5-6) , 391-399
- https://doi.org/10.1016/s0960-0760(97)00054-x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The expression of prostatic acid phosphatase is transcriptionally regulated in human prostate carcinoma cellsMolecular and Cellular Endocrinology, 1995
- Effect of androgens on the germ cell‐depleted testes of prenatally irradiated ratsInternational Journal of Andrology, 1995
- Inverse relationships between cell proliferation and basal or androgen-stimulated apolipoprotein D secretion in LNCaP human prostate cancer cellsThe Journal of Steroid Biochemistry and Molecular Biology, 1994
- Androgen regulation of the messenger RNA encoding diazepam-binding inhibitor/acyl-CoA-binding protein in the human prostatic adenocarcinoma cell line LNCaPMolecular and Cellular Endocrinology, 1994
- Antagonism of androgen action in prostate tumor cells by retinoic acidThe Prostate, 1994
- Effect of culture conditions on androgen sensitivity of the human prostatic cancer cell line LNCaPThe Prostate, 1993
- Steroids and the prostateThe Journal of Steroid Biochemistry and Molecular Biology, 1991
- Growth-inhibitory effects of 1,25-dihydroxyvitamin D3 on normal human keratinocytes cultured in serum-free mediumBiochemical and Biophysical Research Communications, 1990
- Increased epidermal growth factor receptor level in breast cancer cells treated by 1,25-dihydroxyvitamin D3Molecular and Cellular Endocrinology, 1989
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979